Arndt T, Wedekind D, Weiss H, Tiedge M, Lenzen S, Hedrich H-J, Jörns A
Institute of Clinical Biochemistry, Hannover Medical School, Hannover, Germany.
Diabetologia. 2009 Jul;52(7):1381-90. doi: 10.1007/s00125-009-1348-1. Epub 2009 Apr 15.
AIMS/HYPOTHESIS: The LEW.1AR1-iddm rat is an animal model of spontaneous type 1 diabetes mellitus. This study analysed how adoptive transfer of selective T cell subpopulations affects the incidence of diabetes.
CD4(+) or CD8(+) T cells were isolated from diabetic LEW.1AR1-iddm rats or diabetes-resistant LEW.1AR1 rats. Cells were selectively transferred into athymic LEW.1AR1-Whn ( rnu ) or prediabetic LEW.1AR1-iddm rats. The animals were monitored for blood glucose, islet infiltration and immune cell composition of pancreas-draining lymph nodes.
After adoptive transfer of CD4(+) T cells from diabetic LEW.1AR1-iddm rats into athymic LEW.1AR1-Whn ( rnu ) rats, 50% of the recipients developed diabetes. Transfer of CD8(+) T cells failed to induce diabetes. Only 10% of the athymic recipients became diabetic after co-transfer of CD4(+) and CD8(+) T cells. Adoptive transfer of CD8(+) T cells from LEW.1AR1 or diabetic LEW.1AR1-iddm rats into prediabetic LEW.1AR1-iddm rats significantly reduced the incidence of diabetes. In protected normoglycaemic animals regulatory CD8(+)/CD25(+) and CD4(+)/CD25(+) T cell subpopulations that were also FOXP3-positive accumulated in the pancreas-draining lymph nodes. In this lymphatic organ, gene expression of anti-inflammatory cytokines was significantly higher than in diabetic rats.
CONCLUSIONS/INTERPRETATION: Our results show that adoptive transfer of CD4(+) but not CD8(+) T cells from diabetic LEW.1AR1-iddm rats induced diabetes development. Importantly, CD8(+) T cells from diabetic LEW.1AR1-iddm rats and diabetes-resistant LEW.1AR1 rats provided protection against beta cell destruction. The accumulation of regulatory T cells in the pancreas-draining lymph nodes from protected rats indicates that transferred CD8(+) T cells may have beneficial effects in the control of beta cell autoimmunity.
目的/假设:LEW.1AR1 - iddm大鼠是自发性1型糖尿病的动物模型。本研究分析了选择性T细胞亚群的过继转移如何影响糖尿病的发病率。
从糖尿病LEW.1AR1 - iddm大鼠或抗糖尿病的LEW.1AR1大鼠中分离出CD4(+)或CD8(+) T细胞。将细胞选择性地转移到无胸腺的LEW.1AR1 - Whn (rnu)大鼠或糖尿病前期的LEW.1AR1 - iddm大鼠体内。监测动物的血糖、胰岛浸润情况以及胰腺引流淋巴结的免疫细胞组成。
将糖尿病LEW.1AR1 - iddm大鼠的CD4(+) T细胞过继转移到无胸腺的LEW.1AR1 - Whn (rnu)大鼠后,50%的受体发生了糖尿病。CD8(+) T细胞的转移未能诱发糖尿病。在同时转移CD4(+)和CD8(+) T细胞后,只有10%的无胸腺受体发生了糖尿病。将LEW.1AR1或糖尿病LEW.1AR1 - iddm大鼠的CD8(+) T细胞过继转移到糖尿病前期的LEW.1AR1 - iddm大鼠中,可显著降低糖尿病的发病率。在血糖正常的受保护动物中,胰腺引流淋巴结中积累了同时也是FOXP3阳性的调节性CD8(+)/CD25(+)和CD4(+)/CD25(+) T细胞亚群。在这个淋巴器官中,抗炎细胞因子的基因表达明显高于糖尿病大鼠。
结论/解读:我们的结果表明,将糖尿病LEW.1AR1 - iddm大鼠的CD4(+)而非CD8(+) T细胞过继转移可诱发糖尿病的发展。重要的是,糖尿病LEW.1AR1 - iddm大鼠和抗糖尿病LEW.1AR1大鼠的CD8(+) T细胞可提供针对β细胞破坏的保护作用。受保护大鼠胰腺引流淋巴结中调节性T细胞的积累表明,转移的CD8(+) T细胞可能在控制β细胞自身免疫方面具有有益作用。